OC
IMPV

Oppenheimer & Co’s Imperva, Inc. IMPV Stock Holding History

Oppenheimer & Co’s Portfolio IMPV Stock Details IMPV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-4,591
Closed -$222K – 1415
2018
Q2 		$222K Buy
+4,591
New +$220K 0.01% 1182
2017
Q2 		– Sell
-8,950
Closed -$367K – 1379
2017
Q1 		$367K Sell
8,950
-655
-7% -$27.3K 0.01% 919
2016
Q4 		$369K Buy
+9,605
New +$390K 0.01% 922

Other funds holding IMPV

EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Oppenheimer & Co's IMPV Position: Q3 2018 in Review

Oppenheimer & Co sold out of Imperva, Inc. (IMPV) in Q3 2018, closing a stake of 4,591 shares — an estimated $222K sold.

Oppenheimer & Co first reported a position in IMPV in Q4 2016 and held it in 3 quarters. The position peaked at $369K in Q4 2016. 168 funds tracked by Wall St. Rank hold IMPV as of Q3 2018.

  • Oppenheimer & Co reported no remaining Imperva, Inc. position as of Q3 2018 after selling out during the quarter.
  • Oppenheimer & Co sold 4,591 Imperva, Inc. shares in Q3 2018, an estimated $222K.
  • Oppenheimer & Co first reported a position in Imperva, Inc. in Q4 2016 and held it in 3 quarters.
  • Oppenheimer & Co's Imperva, Inc. position peaked at $369K in Q4 2016.
  • 168 funds tracked by Wall St. Rank held Imperva, Inc. as of Q3 2018.

Based on Oppenheimer & Co's 13F filing for Q3 2018, filed 26 Oct 2018.